Dhaka, Sept. 29 -- The US will not impose an ad valorem tariff on certain specialty drugs and associated ingredients imported from Bangladesh and 19 other jurisdictions.

The US Department of Commerce has listed Bangladesh among the jurisdictions eligible for the tariff adjustment, which takes effect on Tuesday.

On Apr 2, US President Donald Trump issued a proclamation imposing tariffs on imports of patented pharmaceuticals, biologics and associated ingredients as part of efforts to encourage domestic production.

The zero-tariff treatment applies to specified categories of specialty pharmaceuticals, rather than all medicines exported from Bangladesh.

Eligible products include drugs and ingredients for which all approved indications are...